350 rub
Journal Technologies of Living Systems №2 for 2011 г.
Article in number:
MICROCIRCULATION FEATURES AT PATIENTS WITH DIABETES TYPE 2
Keywords: diabetes type 2 vital nail bed capillaroscopy
Authors:
Yu.I. Gurfinkel, O.V. Makeeva
Abstract:
Progress and prognosis of a diabetes type 2 depend on a degree of macro- and microcirculation changes, because all organs and tissues involve in pathological process. The purpose of study: to reveal microcirculation features at patients with diabetes type 2. Patients with diabetes (n=55) were divided into two groups: patients without hypertension (18 people) and patents with hypertension (n=37). Thirty three healthy volunteers formed control group. To study capillary blood flow in nail bed the computer capillariscope developed by Russian company «AET» was used. Microcirculation parameters, such as density of a capillary network, di-ameters of a capillaries in arterial, transition, and vein segments, width and length of a capillary loop, coefficient of remodeling of capillaries were determined. Our study established at patients with diabetes type 2 remodeling and expressed tortuosity of capillaries manifested even at earlier stage of disease. Narrowing of capillary loops and rarefaction of a capillary network were also revealed.
Pages: 44-50
References
  1. Шестакова М.В., Дедов И.И. Сахарный диабет и хроническая болезнь почек. М. 2009. С. 17.
  2. Tooke J.E.Methodologies used in the Study of the Microcirculation in Diabetes Mellitus Diabetes // Metabolism Reviews. 1993. V. 9. № 1. P. 57-70.
  3. Avogaro A., Calo L., Piaruli F.Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the rote of nitric oxide // Diabetes. 1999. V. 48. P. 391-397.
  4. Luscher T.F.Endothelial dysfunction: the role and impact of the renin-angiotensin system // Heart. 2000.V. 84 (Suppl. I). P. 20-225.
  5. Pfeiffer A., Schatz H. Diabetic microvascular complications and growth factors // Experimental Clinical Endocrinology and Diabetes. 1995. V. 103(Suppl. I). P. 7-14.
  6. Pickup J.C., Crook M.A. Is Type II diabetes mellitus a disease of innate immune system - // Diabetologia. 1998. V. 41. P. 1241-1248.
  7. Meyer M.F., Schatz H. Influence of metabolic control and duration of disease on microvascular dysfunction in diabetes assessed by laser Doppler anemometry // Experimental Clinical Endocrinology and Diabetes. 1998. V. 106. P. 395-403.
  8. Brownlye M.Biochemistry and mole­cular cell biology of diabetic compli­cations // Nature. 2001. V. 414. P. 813-820.
  9. Профилактика, диагностика и лечение артериальной гипертензии: Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов // Кардиоваскулярная терапия и профилактика. 2008. 7(6). Приложение 2008.
  10. Guidelines for the management of Arterial hypertension // Journal of Hypertension. 2007. V. 25. P. 1105-1187.
  11. Luscher T.P., d'Uscio L.V. Microcirculation and endothelium // Microcirculation and cadiovascular disease. London. 2000. P. 31-45.
  12. JenningsP. Механизмы, лежащие в основе развития диабетической микроангиопатии // Диабетография. 1995. № 3. P. 22-24.
  13. Bohlen H.G.Microvascular Consequences of Obesity and Diabetes // Handbook of physiology Microcirculation. 2008.Chapter 19. P. 895-898.
  14. Brunner H., Cockcroft J.R., Deanfield J. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases // Hypertension. 2005. V. 23. P. 233-246.
  15. Edelstein S.L., Knowler W.C., Bain R.P. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies // Diabetes. 1997. V. 46. P. 701-710.
  16. The DECODE Study Group, the European Diabetes Epidemiology Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria // Arch. Intern. Med. 2001. V. 61. P. 397-405.
  17. De Vegt F., Dekker J. M., Jager A., Hienkens E., Kostense P. J., Stehouwer C. D. A., Nijpels G., Bouter L.M., Heine R. J. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn study // JAMA. 2001. V. 285.
    P. 2109-2113.
  18. Balas P., Pangratis N. The diagnostic investigation using vital capillary microscopy and dynamic capillaroscopy // Clinical Hemorheology and Microcirculation. 1997. Sept-Oct.V.17(5). P. 371-383.
  19. Bonetti P.O., Pumper G.M., Higano S. T. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia // Cardiology. 2004. V. 44. P. 2137-2141.
  20. De Vegt F., Dekker J. M., RuhØ H. G., Stehouwer C. D. A., Nijpels G., Bouter L. M., Heine R. J. Hyperglycemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study // Diabetologia. 1999. V.42. P. 926-931.
  21. Levitan E. B., Song Y., Ford E. S., Liu S. Is non-diabetic hyperglycemia a risk factor for cardiovascular disease - A meta-analysis of prospective studies // Arch. Intern. Med. 2004. V.164. P. 2147-2155.
  22. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macro and microvascular complications in type 2 diabetes: UKPDS 38 // BMJ. 1998. V. 317. P. 703-713.